Methods comprising apoptosis inhibitors for the generation of transgenic pigs

Stem Cell Clinic
Patient Application
FAQ
Contact
Locations
News
Videos
Research
Patents
3D Culture/Scaffold
Administration
Differentiation
Expansion
Extraction/Preservation
Mobilization
Type
USE
 


Stem Cell Related Patent Number US5942487

Title:Composition for treating cornea
Inventors:Ogawa, Takahiro; Nishinomiya, Japan
Tokushige, Hideki; Kobe, Japan
Watanabe, Noriko; Suita, Japan
Summary:This invention introduces a novel composition for the treatment of corneal epithelial defects. Described herein is a pharmaceutical composition comprised of a stem cell factor which is administered either systemically or locally to the surface of the eye to correct corneal epithelial disorders or injuries. Methods and materials are fully disclosed. Therapeutic examples are included for the treatment of dry eye syndrome and other corneal infective diseases.
Abstract:A pharmaceutical composition comprising a stem cell factor (SCF) is administered systemically or locally, preferably administered locally to the eye surface to promote the healing of corneal disorder or injured part in comparison with untreated control.
US Patent Website:Click Here for Full Text of Patent
Title Number:US5942487
Application Number:US1997000976088
Date Filed:21/11/1997
Date Published:24/08/1999
Assignee:Senju Pharmaceutical Co., Ltd., Osaka, Japan


 
Copyright © 2007 The Institute for Cellular Medicine  8/13/2020